Reporters Talk Measles, Pediatric Care, and Democrats’ Post-Election Healthcare Agenda
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
The independent source for health policy research, polling, and news.
1-20 of 3,740 results
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
A young survivor of gun violence lived on the third floor of a St. Louis children’s hospital, moving through the halls in a wheelchair, on and off for over three years. He said it became his home when he had nowhere safe to go.
Harm reduction proponents say testing street drugs prevents overdoses by allowing people to make more informed decisions about what they’re using, but the Trump administration contends that it promotes drug use.
All but vanquished a quarter century ago, measles has taken root again in the U.S. Compared with prior administrations, President Donald Trump’s second term has been marred by misinformation and actions that stifle public health.
The Democrats’ near sweep of the midterms has placed health reform firmly near the top of the national agenda. As fodder for the debate, KFF Health News chief Washington correspondent Julie Rovner launched a project this year called “How Would You Fix It?” It features interviews with public officials, stakeholders, and thought leaders from across the ideological spectrum about how to make the U.S. healthcare system work better. This week’s podcast features insights from entrepreneur Mark Cuban, Sen. Bill Cassidy (R-La.), and Sen. Andy Kim (D-N.J.).
Much of the questionable opioid settlement spending in 2025 occurred at the county and city level, where decision-makers often have no background in addiction policy.
State and local governments are using some of their opioid settlement dollars for initiatives to curb homelessness. The spending raises concerns that those investments don’t always focus on addiction, as many believe the money is meant to.
Public health experts are finding ways to encourage firearm safety practices for older adults who own guns, especially when there are indications of cognitive decline.
KFF Health News journalists made the rounds on national and local media in recent weeks to discuss topical stories. Here’s a collection of their appearances.
The predicted blue wave in the 2026 midterms not only appeared — it overperformed, with Democrats sweeping into majorities in the House and Senate. That sets up a new focus on health policy, with Democrats seeking to undo cuts imposed by President Donald Trump and the GOP-led Congress and advance their own agenda to increase coverage and lower costs. In this special episode, host Julie Rovner is joined by Mollyann Brodie, executive vice president and chief operating officer at KFF; Larry Levitt, KFF’s executive vice president for health policy; and Amanda Seitz, Washington health policy reporter for KFF Health News.
Democrats’ retaking of Congress doesn’t change President Donald Trump’s control of the veto pen — making the new majority’s aspirations to reverse changes to Medicaid, the Affordable Care Act, and other safety net programs an uphill climb.
The federal Office of Refugee Resettlement is supposed to care for migrant children who arrive in the country alone. But new policies are stranding kids in shelters and undermining their mental health. Some children have chosen to return to the countries they fled.
Opposition to the rapid emergence of data centers in states such as Ohio and Arizona has ginned up activism and unified voters. A range of public health issues have played into the resistance.
Poisons from Jacksonville, Florida’s “Brown’s Dump” seeped into the lifeblood of residents. The harm to their physical and mental health is tied today to another public health crisis: high rates of gun violence among children.
Republicans tried to backload Medicaid cuts in 2025’s One Big Beautiful Bill Act so they would take effect after this year’s elections, but that’s not stopping Democrats from using them to hammer their opponents. Meanwhile, the Trump administration ramps up its war on fraud. Alice Miranda Ollstein of Politico, Amanda Seitz of KFF Health News, and Liz Essley Whyte of The Wall Street Journal join KFF Health News’ Julie Rovner to discuss these stories and more. Also, Rovner speaks with Ollstein about her new book, “Side Effects.”
The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
Experimental peptides are all the rage on longevity and “optimization” podcasts, but a lot of the chatter is misleading.
Amid a decline in youth mental health, momentum builds for a federal crackdown on social media companies over protections for kids.
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
© 2026 KFF